Skip to main content

Governance

Ecraid is a not-for-profit foundation that employs a Management Board, a central operational service, and central support staff at our headquarters in Utrecht, the Netherlands.

The Management Board is responsible for the overall coordination and management of Ecraid and is supervised by a Supervisory Board.

Ecraid's Coordinating Committee is tasked with strategic guidance and important decisions. It comprises some of Europe's leading experts in infectious diseases.

Scientific guidance is provided by our Scientific Advisory Board.

  
explore

Coordinating Committee

The Ecraid Coordinating Committee functions as the central body within Ecraid and is responsible for the European-wide coordination of clinical studies on infectious diseases, strategy development, stakeholder management, and service and network development.

Marc Bonten
Chair, Ecraid Chief Executive Officer
CLIN-Net

Evelina Tacconelli
Chief Scientific Officer Ecraid
EPI-Net, LOTTA-Net, ORCHESTRA

Sibyl Anthierens
Public engagement

Roger Brüggemann
Pharmacology, pharmaceutical support, Pharmacometrics (P3) network

Christopher Butler
ECRAID-Prime, POS-ARI-PC, PRUDENCE

Oliver Cornely
VACCELERATE

Jacques Demotes-Mainard
ECRIN, Data management

Lennie Derde
REMAP-CAP

Bruno François
POS-VAP

Carlo Giaquinto
PENTA-ID, VERDI

Stephan Harbarth
STAT-Net

Peter Horby
POS-ARI-ER, MERMAIDS 2.0

Thomas Jaenisch
RECODID, Data sharing

Marion Koopmans
Outbreak preparedness and response, POS-Disease X, VEO

Surbhi Malhotra
LAB-Net

Pontus Naucler
Vice chair Ecraid Clinical Liaison Council

Jesús Rodriguez Baño
POS-cUTI

Oana Săndulescu 
Chair Ecraid Clinical Liaison Council

Arjana Tambić Andrašević
Capacity building, Eastern Europe

Yazdan Yazdanpanah
EU-RESPONSE

 

Scientific Advisory Board

Ecraid's Scientific Advisory Board provides the Coordinating Committee with expert advice and feedback on its services, network composition, innovative trial designs and technologies, as well as ethics, among others.

Evelina Tacconelli
Chair, Chief Scientific Officer Ecraid
University of Verona

Frank Møller Aarestrup 
Technical University of Denmark 

Antonino Di Caro
Unicamillus International University of Medicine Rome

Xavier De Lamballerie 
Aix Marseille University

Vance Fowler
Duke University, Antibiotic Resistance Leadership Group

Nina Gobat
University of Oxford

Nicole Lurie 
Coalition for Epidemic Preparedness Innovations 

Marc Mendelson
University of Cape Town

Seamus O’Brien
Global Antibiotic Research and Development Partnership

David Paterson
University of Queensland
ADVANCE-ID

Hervé Raoul 
INSERM

Guy Thwaites
Clinical Research Unit, University of Oxford 

Robert Weinstein 
Rush University, Chicago

Marco Cavaleri 
Observer to the Scientific Advisory Board
European Medicines Agency

 

Supervisory Board

The Supervisory Board ensures that the Management Board manages the foundation in accordance with the mission, identity, and objectives of Ecraid and that it acts and performs adequately. The Supervisory Board consists of global scientific experts and representatives of leading European and international scientific projects, networks, and organisations with activities complementary to Ecraid's.

Arno Hoes
Chair
Executive Board member and Dean at UMC Utrecht, the Netherlands

Annie van Broekhoven
Managing Director, CreaBioSupport BVBA, Belgium

Deborah Cook
Academic Chair of Critical Care, McMaster University, Canada

Juan Emilio Echevarría
Laboratory Head, Instituto de Salud Carlos III, Spain 

Bernard Pécoul
Former Executive Director Drugs for Neglected Diseases initiative, Switzerland 

Momir Radulović
Observer to the Supervisory Board
Board member European Medicines Agency, Executive Director Slovenian Medicines Agency, Slovenia